281 related articles for article (PubMed ID: 29751285)
21. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
22. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
[TBL] [Abstract][Full Text] [Related]
23. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
[TBL] [Abstract][Full Text] [Related]
24. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
[TBL] [Abstract][Full Text] [Related]
25. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
26. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
Tada H; Takamura M; Kawashiri MA
Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
[TBL] [Abstract][Full Text] [Related]
27. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
29. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
[TBL] [Abstract][Full Text] [Related]
30. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
[TBL] [Abstract][Full Text] [Related]
32. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
33. Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
Humphries SE; Cooper JA; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil AHW;
Atherosclerosis; 2019 Feb; 281():207-212. PubMed ID: 30458964
[TBL] [Abstract][Full Text] [Related]
34. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus?
Humphries SE
Atheroscler Suppl; 2011 Oct; 12(2):217-20. PubMed ID: 22230092
[No Abstract] [Full Text] [Related]
36. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
[TBL] [Abstract][Full Text] [Related]
37. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
[TBL] [Abstract][Full Text] [Related]
38. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
[TBL] [Abstract][Full Text] [Related]
39. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
40. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
